Status:
UNKNOWN
Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Hemorrhoids
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Purpose of study is evaluation of Allium ampeloprasum Spp.Iranicum cream efficacy in management of symptomatic hemorrhoids in a double blind randomized placebo-control trial
Detailed Description
Purpose of study: evaluation of Allium ampeloprasum Spp.Iranicum cream efficacy for the management of hemorrhoids study design:Double blind randomized placebo-control trial, uni-central Study populati...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Participants having symptomatic hemorrhoids(GRADE 1-4) without need to emergency operation according to physical examination
- Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period:
- Exclusion Criteria:
- Participants having anal fissure or inflammatory bowel disease or history of gastrointestinal cancer
- Participants having hypersensitive predisposition or hypersensitive to Allium ampeloprasum or history of skin hypersensivity
- Female participants under pregnancy or during breastfeeding period
- Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or neurologic disorders or ascitis g- history of steroid or anticoagulant drug consumption
Exclusion
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02301052
Start Date
September 1 2014
End Date
December 1 2014
Last Update
November 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vice-Chancellery of Research and Technology office, Shiraz University of Medical Sciences
Shiraz, Fars, Iran, 009871